Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Annette M Molinaro

Showing results (191-200 of 208) with videos related to

Pageof 21
Sort By:
Neuro-Oncology|May 30, 2023
Prognostic evaluation of re-resection for recurrent glioblastoma using the novel RANO classification for extent of resection: A report of the RANO resect groupPhilipp Karschnia, Antonio Dono, Jacob S Young, et al.
Neuro-Oncology|September 4, 2023
Surgical management and outcome of newly diagnosed glioblastoma without contrast enhancement (low-grade appearance): a report of the RANO resect groupPhilipp Karschnia, Jorg Dietrich, Francesco Bruno, et al.
Nature|May 3, 2023
Glioblastoma remodelling of human neural circuits decreases survivalSaritha Krishna, Abrar Choudhury, Michael B Keough, et al.
Science Advances|June 4, 2025
Predicting therapeutic clinical trial enrollment for adult patients with low- and high-grade glioma using supervised machine learningMulki Mehari, Gayathri Warrier, Abraham Dada, et al.
Neuro-Oncology|October 25, 2025
Associations of supramaximal resection with outcome in glioblastoma across age groups: a report of the RANO resect groupNico Teske, Antonio Dono, Jacob S Young, et al.
Neuro-Oncology|April 8, 2022
Prospective genomically guided identification of "early/evolving" and "undersampled" IDH-wildtype glioblastoma leads to improved clinical outcomesYalan Zhang, Calixto-Hope G Lucas, Jacob S Young, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2017
Prospective Feasibility Trial for Genomics-Informed Treatment in Recurrent and Progressive GlioblastomaSara A Byron, Nhan L Tran, Rebecca F Halperin, et al.
Neuro-Oncology|November 4, 2024
Development and validation of a clinical risk model for postoperative outcome in newly diagnosed glioblastoma: A report of the RANO resect groupPhilipp Karschnia, Jacob S Young, Gilbert C Youssef, et al.
Nature Genetics|June 9, 2014
Variants near TERT and TERC influencing telomere length are associated with high-grade glioma riskKyle M Walsh, Veryan Codd, Ivan V Smirnov, et al.
Acta Neuropathologica|December 11, 2023
"De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockadeSara Hadad, Rohit Gupta, Nancy Ann Oberheim Bush, et al.
Pageof 21

Showing results (191-200 of 208) with videos related to

Sort By:
Pageof 21
Neuro-Oncology|May 30, 2023
Prognostic evaluation of re-resection for recurrent glioblastoma using the novel RANO classification for extent of resection: A report of the RANO resect groupPhilipp Karschnia, Antonio Dono, Jacob S Young, et al.
Neuro-Oncology|September 4, 2023
Surgical management and outcome of newly diagnosed glioblastoma without contrast enhancement (low-grade appearance): a report of the RANO resect groupPhilipp Karschnia, Jorg Dietrich, Francesco Bruno, et al.
Nature|May 3, 2023
Glioblastoma remodelling of human neural circuits decreases survivalSaritha Krishna, Abrar Choudhury, Michael B Keough, et al.
Science Advances|June 4, 2025
Predicting therapeutic clinical trial enrollment for adult patients with low- and high-grade glioma using supervised machine learningMulki Mehari, Gayathri Warrier, Abraham Dada, et al.
Neuro-Oncology|October 25, 2025
Associations of supramaximal resection with outcome in glioblastoma across age groups: a report of the RANO resect groupNico Teske, Antonio Dono, Jacob S Young, et al.
Neuro-Oncology|April 8, 2022
Prospective genomically guided identification of "early/evolving" and "undersampled" IDH-wildtype glioblastoma leads to improved clinical outcomesYalan Zhang, Calixto-Hope G Lucas, Jacob S Young, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 28, 2017
Prospective Feasibility Trial for Genomics-Informed Treatment in Recurrent and Progressive GlioblastomaSara A Byron, Nhan L Tran, Rebecca F Halperin, et al.
Neuro-Oncology|November 4, 2024
Development and validation of a clinical risk model for postoperative outcome in newly diagnosed glioblastoma: A report of the RANO resect groupPhilipp Karschnia, Jacob S Young, Gilbert C Youssef, et al.
Nature Genetics|June 9, 2014
Variants near TERT and TERC influencing telomere length are associated with high-grade glioma riskKyle M Walsh, Veryan Codd, Ivan V Smirnov, et al.
Acta Neuropathologica|December 11, 2023
"De novo replication repair deficient glioblastoma, IDH-wildtype" is a distinct glioblastoma subtype in adults that may benefit from immune checkpoint blockadeSara Hadad, Rohit Gupta, Nancy Ann Oberheim Bush, et al.
Pageof 21